Experts discussed the rapidly expanding radiopharmaceutical paradigm and how to integrate such technology into real-world oncology practice.
Neil K. Taunk, MD, MSCTS
Advertisement
Articles by Neil K. Taunk, MD, MSCTS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Zanidatamab-Based Regimens for First-Line HER2+ Gastric Cancers
2
FDA Grants Fast Track Designation to ERAS-0015 for Pancreatic Adenocarcinoma
3
Sevabertinib Earns Japanese Approval Across All Lines in HER2-Mutant NSCLC
4
Lenvatinib Combo Holds Ground Against HER2 ADCs in Endometrial Cancer
5